Skip to content
The Policy VaultThe Policy Vault

Rydapt (midostaurin capsules)Cigna

Smoldering Systemic Mastocytosis

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has tried at least one systemic regimen (example of a systemic regimen includes Ayvakit [avapritinib tablets])

Approval duration

1 year